Auriga reiterates a 'Buy' rating on Genoptix (Nasdaq: GXDX), raises price target from $39 to $43.

Auriga analyst says, "Genoptix ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE